Onconova Therapeutics Inc. (NASDAQ: ONTX) Onconova is another pure-play biotech penny stock working on clinical-stage pharmaceuticals. Updated world stock indexes. A company’s book value is the net asset value (NAV) of a company. Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more To calculate book value, subtract a company’s liabilities from its assets. Get an overview of major world indexes, current values and stock market data. Onconova Therapeutics Inc. (ONTX) shares are taking a pay cut of -72.75% from the high point of 52 weeks and flying high of 176.70% from the low figure of 52 weeks. Then divide that result by the number of common shares outstanding. The 52-week price high and low points are important variables to concentrate on when assessing the current and prospective worth of a stock. 2. This includes its proprietary multi-kinase inhibitor known as ON-123300. Its focus is on treatments for cancer, including targeted anti-cancer therapeutics that disrupt specific cellular pathways.
Lindey's German Village,
Craft Organizer Cabinet,
Vata, Pitta, Kapha Test,
Minimum Wage For Federal Employees,
Todd County Mn Jail Roster,
Ott Player For Panasonic Smart Tv,
Al Zorah Marina Restaurants,
Car Accidents In Maine This Week,
Blender Grease Pencil Onion Skin,
Jerry Krause Cause Of Death,